Stereotaxis, Inc. (STXS) Financials

STXS Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 54.0 million 34.4 million
Dec. 31, 2025 52.3 million 33.5 million
Sept. 30, 2025 45.6 million 34.1 million
June 30, 2025 41.2 million 34.4 million

STXS Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -3.5 million 2.1 million
Dec. 31, 2025 -4.0 million 2.4 million
Sept. 30, 2025 -4.2 million 2.5 million
June 30, 2025 -3.8 million 2.4 million

STXS Net Income

No data available :(

STXS Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 14.6 million - 4.6 million
Dec. 31, 2025 13.4 million - 4.8 million
Sept. 30, 2025 10.5 million - 5.6 million
June 30, 2025 7.0 million - 5.7 million

STXS Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 98.9 million
Dec. 31, 2025 96.0 million
Sept. 30, 2025 92.0 million
June 30, 2025 87.9 million

STXS Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 79000 2.4 million 7.4 million 2.6 million
Dec. 31, 2025 70000 2.7 million 7.3 million 3.1 million
Sept. 30, 2025 - 2.5 million 8.1 million 2.9 million
June 30, 2025 23000 1.8 million 7.3 million 3.3 million

STXS Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 6.3 million 2.5 million
Dec. 31, 2025 8.6 million 4.3 million
Sept. 30, 2025 7.5 million 3.4 million
June 30, 2025 8.8 million 4.2 million

STXS Revenue by Segment
Graph available only for paid members. Upgrade to see it.

STXS

Price: $1.84

52 week price:
1.73
3.59

Earnings Per Share: -0.24 USD

Exchange: ASE

Sector: Healthcare

Industry: Medical Instruments & Supplies

Country: United States

Volume: 50343

Ebitda: -5.0 million

Market Capitalization: 180.8 million

Links: